QUOTE-IBDを用いた患者の視点から炎症性腸疾患におけるケア品質:ギリシャの多センター展望研究
Aikaterini Mantaka1, Ioannis Apostolakis2,3, Phillippe-Richard Domeyer3
1Department of Gastroenterology, 'Saint George' General Hospital of Chania.
European journal of gastroenterology & hepatology
|September 3, 2025
まとめ
ギリシャの炎症性腸疾患 (IBD) 治療に対する患者の見解は,全体的に高い品質を示していますが,アクセシビリティと共有された意思決定は改善する必要があります. クローン
科学分野:
- 胃腸科と肝臓科
- 医療サービス研究
- 患者による報告結果
背景:
- 既存のケア品質 (QoC) 評価は,患者の経験と異なる可能性のある提供者の認識に依存しています.
- 患者の報告されたQCを理解することは,炎症性腸疾患 (IBD) などの慢性疾患における医療の提供を改善するために不可欠です.
研究 の 目的:
- ギリシャのコホート (GR QUOTE-IBD) で,IBD患者自身の視点からQoCを測定する.
- IBDにおける患者報告のQCに影響を与える社会統計学的および疾患関連の要因を特定する.
主な方法:
- GR QUOTE- IBDアンケートは,150人のIBD患者に対して,定期的な追跡調査で実施された.
- 患者の反応と疫学および疾患の特徴を相関させ,データを分析した.
- 統計分析はSPSS バージョン29を用いた.
主要な成果:
- 医療の総合品質指数 (QI) は,参加したすべての病院で9を超えました.
- 3つの診療所のうち2つの診療所では,IBD治療へのアクセスの質の欠陥 (QI < 9) が認められた.
- クローン病 (CD) の診断は総合ケアQIと正の相関関係 (P=0. 013),過去のステロイド治療は負の相関関係 (P=0. 019) であった.
結論:
- クレタ島におけるIBD患者の全体的なQoCは高いと考えられています.
- IBDの治療に対する患者の認識は,診断 (CD) と疾患の重度によって影響を受けます.
- IBDの治療へのアクセスの向上と 共同意思決定の促進が臨床医に推奨されています.
関連する概念動画
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413
01:30Inflammatory Bowel Disease II: Crohn's Disease
375
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
375
01:29Inflammatory Bowel Disease IV: Pharmacological Management
185
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
185
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
316
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
316
01:17Chronic Bowel Disorders: Introduction
540
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
540
01:21Inflammatory Bowel Disease V: Surgical Management
206
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
206